- home |
- tell a friend |
- print page |
- contact us |
- links
Risks of Surgery
A brief description of relevant contraindications, warnings and adverse events of the adjustable gastric band (AGB)
Indications: The AGB is indicated for use in weight reduction for severely obese patients with a Body Mass Index (BMI) of at least 40 or a BMI of at least 35 with one or more severe co-morbid conditions, or those who are approximately 100 lbs. or more over their estimated ideal weight.
Contraindications: The AGB is not recommended for non-adult patients (may be evaluated on a case-by-case basis), patients with conditions that may make them poor surgical candidates or increase the risk of poor results, who are unwilling or unable to comply with the required dietary restrictions, or who currently are or may shortly become pregnant.
Warnings: The AGB is a long-term implant. There is potential that Explant (removal) and/or replacement surgery may be required at some time. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Patients should not expect to lose weight as quickly as gastric bypass patients (but results are virtually equal at 3 years), and band inflation should proceed in small increments. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.
Adverse Events: Placement of the AGB is major surgery and, like any surgery, death can occur (mortality rate of 0-0.05% or 0-1/2000). Possible complications include the risks associated with any surgical procedure.
Band slippage (1-3% risk), erosion (less than 1% risk), obstruction of the stomach, dilation of the esophagus, port problems, infection, or nausea and vomiting may occur. Reoperation may be required to treat such complications.
Rapid weight loss may result in complications that can require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.
Not all contraindications, warnings or adverse events are included in this brief description. More detailed risk information is available at www.LAP-BAND.com or www.REALIZEBAND.com.
